<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000635683">
  <TermName>AC-T regimen</TermName>
  <TermPronunciation>(… REH-jih-men)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>An abbreviation for a chemotherapy combination used to treat breast cancer. It includes the drugs doxorubicin hydrochloride (Adriamycin) and cyclophosphamide, followed by treatment with paclitaxel (Taxol). Also called AC-T and AC-Taxol regimen.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000722825" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;AC-T regimen&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000722826" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen AC-T&quot;" language="es" id="_4"/>
  <SpanishTermName>régimen AC-T</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Nombre de una quimioterapia combinada que se usa para el tratamiento del cáncer de mama.   Incluye los medicamentos clorhidrato de doxorrubicina (Adriamycin) y ciclofosfamida, seguidos de tratamiento con paclitaxel (Taxol).   También se llama AC-T y régimen AC-Taxol.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2009-02-20</DateFirstPublished>
  <RelatedInformation>
    <RelatedDrugSummaryRef UseWith="en" href="CDR0000630806" url="/about-cancer/treatment/drugs/AC-T">AC-T</RelatedDrugSummaryRef>
  </RelatedInformation>
</GlossaryTerm>
